DIABETIC MEDICINE-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2023-08-12 ms7000001152426712 来自安徽省

偏重的研究方向：系统评价
经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖

184 9

展开9条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2022-08-25 tyming6945

审稿速度:2.0 | 投稿命中率:25.0
经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用

176 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2021-12-28 学医的彭于晏

如何回复期刊编辑的意见？

179 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2021-12-27 乌云背后的幸福线

回复评审的意见和期刊编辑的意见有什么不同？

186 1

展开1条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2021-04-19 Shirley呀

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：糖尿病;自我管理;系统评价
经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。

0 0

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2020-06-21 146f6ef6m90(暂无昵称)

如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊

269 2

展开2条回复

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2018-11-25 纯碱碳酸钠

该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans."

385 0

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2017-12-04 啾啾啾喵喵

Under Review 是编辑在审吗？

526 0

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2017-07-18 chenyuming

3分边缘，希望能维持稳定，略有上升也不错。

454 0

[GetPortalCommentsPageByObjectIdResponse(id=2152433, encodeId=a7ef2152433f0, content=偏重的研究方向：系统评价 经验分享：7月7号投稿，说是3-4周给结果，今天8月12号了，还是underreview😖😖😖, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=184, replyNumber=9, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=7b415466513, createdName=ms7000001152426712, createdTime=Sat Aug 12 15:39:02 CST 2023, time=2023-08-12, status=1, ipAttribution=安徽省), GetPortalCommentsPageByObjectIdResponse(id=1240949, encodeId=3e10124094988, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：7月14投稿，8月25日返回reviwer意见，，意见比较积极，建议修回再审，不保证录用, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=176, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=6f2a39755, createdName=tyming6945, createdTime=Thu Aug 25 15:34:32 CST 2022, time=2022-08-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089315, encodeId=8d8e10893151b, content=如何回复期刊编辑的意见？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=179, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=81a55564862, createdName=学医的彭于晏, createdTime=Tue Dec 28 14:52:48 CST 2021, time=2021-12-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1089316, encodeId=57e71089316ad, content=回复评审的意见和期刊编辑的意见有什么不同？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=186, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/3d5d7c32f9074d95860d2fb0b87610c7/e46b7b89bc8c409db09184416343fca3.jpg, createdBy=d20e5497900, createdName=乌云背后的幸福线, createdTime=Mon Dec 27 14:52:48 CST 2021, time=2021-12-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958244, encodeId=500895824421, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：糖尿病;自我管理;系统评价 经验分享：投了第二天就under review了，说是3-4w出结果，结果第二周就已经给了拒信。是编辑老师先审核，如果不过关直接拒，所以也没有审稿意见。准备直接投其他杂志。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20211212/206f19bc5ce748f58a48022e978b02c3/307ac41c887642c58fba83e6e626cab4.jpg, createdBy=6ac92165730, createdName=Shirley呀, createdTime=Mon Apr 19 10:28:09 CST 2021, time=2021-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=799331, encodeId=2a5be9933107, content=如今都没人投了吗，我投稿第二天就送审了，还说在3到4周内会给出意见，这是加快了吗😊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=269, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=cd2b5180633, createdName=146f6ef6m90(暂无昵称), createdTime=Sun Jun 21 20:35:38 CST 2020, time=2020-06-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=563622, encodeId=87ff56362279, content=该杂志不接收基础类文章：The journal publishes a range of key information on all clinical aspects of diabetes mellitus, ranging from human genetic studies through clinical physiology and trials to diabetes epidemiology. We do not publish original animal or cell culture studies unless they are part of a study of clinical diabetes involving humans.", beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=385, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0bb92009146, createdName=纯碱碳酸钠, createdTime=Sun Nov 25 19:23:00 CST 2018, time=2018-11-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=549698, encodeId=3afa54969897, content=Under Review 是编辑在审吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=526, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=bf262099033, createdName=啾啾啾喵喵, createdTime=Mon Dec 04 11:50:00 CST 2017, time=2017-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=539341, encodeId=ceae53934197, content=3分边缘，希望能维持稳定，略有上升也不错。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=454, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=chenyuming, createdTime=Tue Jul 18 18:29:00 CST 2017, time=2017-07-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=534825, encodeId=e30453482594, content=这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=476, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=a4b81613798, createdName=sll1234, createdTime=Wed Mar 29 11:09:00 CST 2017, time=2017-03-29, status=1, ipAttribution=)]

2017-03-29 sll1234

这个杂志投稿之后就是underreview，是杂志社内审还是送外审了啊？

476 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务